ReviewThe journal of allergy and clinical immunology. In practice2026
Shrinking Spleens and Nodes, Expanding Horizons: Leniolisib and the Future of Activated Phosphoinositide 3-Kinase Delta Syndrome.
Kittipos Visitsunthorn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.